Pekka Taimen
Papers
4
Total Citations
50
H-Index
4
About
Pekka Taimen is a leading researcher in prostate cancer diagnostics and image-guided therapy, with a particular focus on integrating advanced imaging with histopathological validation. His work centers on the development and evaluation of MRI-guided transurethral ultrasound ablation (TULSA) as a minimally invasive treatment for localized prostate cancer. Taimen’s landmark 2019 study, cited 30 times, established the feasibility and safety of lesion-targeted TULSA, while his subsequent 2020 work characterized the acute and subacute MRI findings after ablation, providing critical guidance for post-treatment monitoring. More recently, he has advanced the field of molecular imaging, leading a prospective comparison of 18F-PSMA-1007 PET/CT and whole-body MRI against histopathology for intraprostatic tumor detection and T-staging in high-risk prostate cancer. Beyond clinical imaging, Taimen has made foundational contributions to preclinical models, critically evaluating subcutaneous engraftments of hormone-naïve primary prostate cancer to improve patient-derived xenograft models. His work bridges the gap between cutting-edge imaging technology, histopathological correlation, and translational oncology, making him a key figure in the evolution of precision prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4